Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study.

Notably, the presence of bone metastasis at diagnosis was associated with shorter TTNT, although this did not reach statistical significance (HR =2.86; 95% CI: 0.98–8.32; P=0.05) ( Table S2 ).

also in 111,027 other papers